Deferred Tax Assets, Gross of Keenova Therapeutics plc from 28 Sep 2012 to 27 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Keenova Therapeutics plc quarterly Deferred Tax Assets, Gross in USD history and change rate from 28 Sep 2012 to 27 Dec 2024.
  • Keenova Therapeutics plc Deferred Tax Assets, Gross for the quarter ending 27 Dec 2024 was $4,499,600,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,499,600,000 -$982,500,000 -18% 27 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $5,482,100,000 -$210,400,000 -3.7% 29 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $5,692,500,000 -$806,400,000 -12% 30 Dec 2022 10-K 26 Mar 2024 2023 FY
Q4 2021 $6,498,900,000 +$157,900,000 +2.5% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q4 2020 $6,341,000,000 +$2,540,800,000 +67% 25 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $3,800,200,000 +$793,800,000 +26% 27 Dec 2019 10-K 10 Mar 2021 2020 FY
Q4 2018 $3,006,400,000 +$520,800,000 +21% 28 Dec 2018 10-K 26 Feb 2020 2019 FY
Q4 2017 $2,485,600,000 +$611,900,000 +33% 29 Dec 2017 10-K 26 Feb 2019 2018 FY
Q4 2016 $1,873,700,000 30 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $982,900,000 +$410,100,000 +72% 30 Sep 2016 10-K 29 Nov 2016 2016 FY
Q3 2015 $572,800,000 +$145,400,000 +34% 25 Sep 2015 10-K 29 Nov 2016 2016 FY
Q3 2014 $427,400,000 +$83,300,000 +24% 26 Sep 2014 10-K 24 Nov 2015 2015 FY
Q3 2013 $344,100,000 +$52,400,000 +18% 27 Sep 2013 8-K 03 Apr 2015 2014 FY
Q3 2012 $291,700,000 28 Sep 2012 10-K 13 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.